Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 131

1.

Use of single and combined antithrombotic therapy and risk of serious upper gastrointestinal bleeding: population based case-control study.

Hallas J, Dall M, Andries A, Andersen BS, Aalykke C, Hansen JM, Andersen M, Lassen AT.

BMJ. 2006 Oct 7;333(7571):726. Epub 2006 Sep 19.

2.

Upper gastrointestinal mucosal abnormalities and blood loss complicating low-dose aspirin and antithrombotic therapy.

Taha AS, Angerson WJ, Knill-Jones RP, Blatchford O.

Aliment Pharmacol Ther. 2006 Feb 15;23(4):489-95.

3.

Nitrovasodilators, low-dose aspirin, other nonsteroidal antiinflammatory drugs, and the risk of upper gastrointestinal bleeding.

Lanas A, Bajador E, Serrano P, Fuentes J, Carreño S, Guardia J, Sanz M, Montoro M, Sáinz R.

N Engl J Med. 2000 Sep 21;343(12):834-9.

4.

Drug drug interactions between antithrombotic medications and the risk of gastrointestinal bleeding.

Delaney JA, Opatrny L, Brophy JM, Suissa S.

CMAJ. 2007 Aug 14;177(4):347-51.

5.

Do statins protect against upper gastrointestinal bleeding?

Gulmez SE, Lassen AT, Aalykke C, Dall M, Andries A, Andersen BS, Hansen JM, Andersen M, Hallas J.

Br J Clin Pharmacol. 2009 Apr;67(4):460-5. doi: 10.1111/j.1365-2125.2009.03362.x.

6.

Association of Antithrombotic Drug Use With Subdural Hematoma Risk.

Gaist D, García Rodríguez LA, Hellfritzsch M, Poulsen FR, Halle B, Hallas J, Pottegård A.

JAMA. 2017 Feb 28;317(8):836-846. doi: 10.1001/jama.2017.0639.

PMID:
28245322
7.

A case-control study of the association between polymorphisms of the endothelial nitric oxide synthase and glycoprotein IIIa genes and upper gastrointestinal bleeding in users of low-dose aspirin.

Piazuelo E, Fuentes J, García-González MA, Jiménez P, Lanas A.

Clin Ther. 2008 Jan;30(1):121-30. doi: 10.1016/j.clinthera.2008.01.020.

PMID:
18343248
8.

Effect of oral antiplatelet agents on major bleeding in users of coumarins.

Schalekamp T, Klungel OH, Souverein PC, de Boer A.

Thromb Haemost. 2008 Dec;100(6):1076-83.

PMID:
19132233
9.

Gastrointestinal bleeding in patients receiving a combination of aspirin, clopidogrel, and enoxaparin in acute coronary syndrome.

Ng FH, Wong SY, Lam KF, Chang CM, Lau YK, Chu WM, Wong BC.

Am J Gastroenterol. 2008 Apr;103(4):865-71. doi: 10.1111/j.1572-0241.2007.01715.x. Epub 2008 Jan 2.

PMID:
18177451
10.

Lower GI bleeding risk of nonsteroidal anti-inflammatory drugs and antiplatelet drug use alone and the effect of combined therapy.

Nagata N, Niikura R, Aoki T, Shimbo T, Kishida Y, Sekine K, Tanaka S, Okubo H, Watanabe K, Sakurai T, Yokoi C, Akiyama J, Yanase M, Mizokami M, Uemura N.

Gastrointest Endosc. 2014 Dec;80(6):1124-31. doi: 10.1016/j.gie.2014.06.039. Epub 2014 Aug 1.

PMID:
25088922
11.

Clinical outcome in upper gastrointestinal bleeding complicating low-dose aspirin and antithrombotic drugs.

Taha AS, Angerson WJ, Knill-Jones RP, Blatchford O.

Aliment Pharmacol Ther. 2006 Aug 15;24(4):633-6.

12.

High incidence of clopidogrel-associated gastrointestinal bleeding in patients with previous peptic ulcer disease.

Ng FH, Wong SY, Chang CM, Chen WH, Kng C, Lanas AI, Wong BC.

Aliment Pharmacol Ther. 2003 Aug 15;18(4):443-9.

13.

Upper gastrointestinal haemorrhage complicating antiplatelet treatment with aspirin and/or clopidogrel: where we are now?

Liberopoulos EN, Elisaf MS, Tselepis AD, Archimandritis A, Kiskinis D, Cokkinos D, Mikhailidis DP.

Platelets. 2006 Feb;17(1):1-6. Review.

PMID:
16308180
14.

Risk of upper gastrointestinal ulcer bleeding associated with selective cyclo-oxygenase-2 inhibitors, traditional non-aspirin non-steroidal anti-inflammatory drugs, aspirin and combinations.

Lanas A, García-Rodríguez LA, Arroyo MT, Gomollón F, Feu F, González-Pérez A, Zapata E, Bástida G, Rodrigo L, Santolaria S, Güell M, de Argila CM, Quintero E, Borda F, Piqué JM; Asociación Española de Gastroenterología.

Gut. 2006 Dec;55(12):1731-8. Epub 2006 May 10.

15.

[Upper gastrointestinal bleeding in patients treated by low-dose aspirin].

Capet C, Czernichow P, Dupas JL, Goria O, Gouérou H, Hochain P, Amouretti M, Herman H, Colin R.

Gastroenterol Clin Biol. 2001 Mar;25(3):233-8. French.

16.

Upper gastrointestinal bleeding associated with antiplatelet drugs.

Ibáñez L, Vidal X, Vendrell L, Moretti U, Laporte JR; Spanish-Italian Collaborative Group for the Epidemiology of Gastrointestinal Bleeding.

Aliment Pharmacol Ther. 2006 Jan 15;23(2):235-42.

17.

Spironolactone use and the risk of upper gastrointestinal bleeding: a population-based case-control study.

Gulmez SE, Lassen AT, Aalykke C, Dall M, Andries A, Andersen BS, Hansen JM, Andersen M, Hallas J.

Br J Clin Pharmacol. 2008 Aug;66(2):294-9. doi: 10.1111/j.1365-2125.2008.03205.x. Epub 2008 Apr 21.

18.

Risk factors of gastrointestinal bleeding in clopidogrel users: a nationwide population-based study.

Lin CC, Hu HY, Luo JC, Peng YL, Hou MC, Lin HC, Lee FY.

Aliment Pharmacol Ther. 2013 Nov;38(9):1119-28. doi: 10.1111/apt.12483. Epub 2013 Sep 15.

19.

Clopidogrel versus aspirin and esomeprazole to prevent recurrent ulcer bleeding.

Chan FK, Ching JY, Hung LC, Wong VW, Leung VK, Kung NN, Hui AJ, Wu JC, Leung WK, Lee VW, Lee KK, Lee YT, Lau JY, To KF, Chan HL, Chung SC, Sung JJ.

N Engl J Med. 2005 Jan 20;352(3):238-44.

20.

Risk of upper gastrointestinal bleeding associated with use of low-dose aspirin.

Sørensen HT, Mellemkjaer L, Blot WJ, Nielsen GL, Steffensen FH, McLaughlin JK, Olsen JH.

Am J Gastroenterol. 2000 Sep;95(9):2218-24.

PMID:
11007221

Supplemental Content

Support Center